Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Ceska Gynekol ; 79(5): 399-406, 2014 Nov.
Article in Czech | MEDLINE | ID: mdl-25472460

ABSTRACT

UNLABELLED: Infection with human papillomavirus is the most common viral sexually transmitted infection that mainly affects younger sexually active population. Genital warts are one of the most common manifestations of this infection. Although not a life-threatening disease, it is difficult to treat and frequent recurrence can traumatize the patient and influence not only his sexual life. Currently there are many treatment possibilities, but none is 100% efficient. Because of the wide range of character manifestation and their different localization is necessary to approach each patient individually. Therefore, there is a major weapon against this disease prevention, a safe sexual behavior and a new vaccination. KEYWORDS: condylomata acuminata, HPV infection, diagnostics, prevention, treatment.

2.
Klin Onkol ; 27(4): 239-46, 2014.
Article in Czech | MEDLINE | ID: mdl-25115712

ABSTRACT

BACKGROUND: There is a considerable number of studies on the efficacy HPV (human papillomavirus) vaccination against different cancers but relevant information is scattered in diverse journals. This paper is a review summarizing current knowledge of the potential of HPV vaccination against all HPV related cancers. AIM: HPV infection is probably the most frequent sexually transmitted disease. At least 13 HPV genotypes are classified as carcinogenic or probably carcinogenic in respect to cervical cancer. Almost 100% of cervical cancers are linked to HPV infection. HPV 16 and HPV 18 are the most frequently involved genotypes and account together for approximately 70% of cervical cancer in the world. Persistent high risk HPV infection is responsible for a significant proportion of vulvar, vaginal, anal and penile carcinomas. The virus has also been implicated in oncogenesis of head and neck cancers, including oropharyngeal cancers. HPV infection can play an important role in cancerogenesis of lung, esophagus, breast, and colon and rectum. On the contrary, published results indicate that HPV infection is not associated with prostate oncogenesis. Strong predominance of HPV 16 has been reported for all HPV associated cancer sites. Generally, it is estimated that approximately 5.2% of all cancers are associated with oncogenic HPV infection. Currently, there are two vaccines on the market; quadrivalent Silgard® (Gardasil®) and bivalent CervarixTM. Large trials for both vaccines have shown efficacy against HPV related infection and disease. Efficacy has been very high in HPV naive subjects to vaccine related types. While HPV vaccination is currently approved for the prevention of cervical cancer, it also has the potential in the prevention of all HPV associated malignancies. The Czech republic belongs to countries that cover HPV vaccination of girls at the age of 13- 14 years by general health insurance. Overall impact of this vaccination remains to be evaluated. The new issues of the role of HPV in oncogenesis, as well as the potential effect of HPV vaccination against HPV related nongenital cancers are discussed. CONCLUSION: Approximately 5.2% of all human cancers are associated with oncogenic human papillomavirus infection. HPV vaccination against the most risky HPV oncotypes may cause a significant reduction of these cancers mainly in the HPV naive population.


Subject(s)
Neoplasms/prevention & control , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/therapeutic use , Vaccination , Anus Neoplasms/prevention & control , Anus Neoplasms/virology , Breast Neoplasms/prevention & control , Breast Neoplasms/virology , Czech Republic , Esophageal Neoplasms/prevention & control , Esophageal Neoplasms/virology , Female , Genital Neoplasms, Female/prevention & control , Genital Neoplasms, Female/virology , Head and Neck Neoplasms/prevention & control , Head and Neck Neoplasms/virology , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 , Humans , Intestinal Neoplasms/prevention & control , Intestinal Neoplasms/virology , Lung Neoplasms/prevention & control , Lung Neoplasms/virology , Male , Neoplasms/virology , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Penile Neoplasms/prevention & control , Penile Neoplasms/virology , Uterine Cervical Neoplasms
3.
Folia Microbiol (Praha) ; 59(2): 115-25, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23929025

ABSTRACT

One hundred twenty-four patients-53 with neuroborreliosis, 48 with erythema migrans, and 23 with Lyme arthritis-were tested in a prospective study for the presence of the DNA of Borrelia burgdorferi sensu lato in plasma, cerebrospinal fluid (CSF), urine, and synovial fluid by nested polymerase chain reaction (PCR). Specific DNA was detected using five amplification systems simultaneously: three targeted chromosomal genes encoding 16S rDNA, flagellin, and p66; and two plasmid sequences of OspA and OspC. Patients were examined clinically and by PCR before and after treatment and again after 3 and 6 months. Before treatment, the specific DNA was detected in 78 patients (62.9 %). Forty-one neuroborreliosis patients were DNA-positive (77.4 %), with CSF positivity in 26 patients, urine in 25, and plasma in 16. Twenty-six erythema migrans patients were DNA-positive (54.2 %), with plasma positivity in 18 cases and urine in 14. Eleven Lyme arthritis cases (47.8 %) were DNA positive (six in urine, five in plasma, and four in synovial fluid). The frequency of PCR positives was comparable in CSF and urine, and it was lower by approximately 50 % in plasma. Specific DNA was also found in a significant number of patients in later testing periods: 48 patients after treatment, 29 patients after 3 months, and 6 patients after 6 months. The prolonged PCR positivity was not explainable by persistent infection according to the clinical manifestations of the disease. Possible explanations of the problem are discussed.


Subject(s)
Borrelia burgdorferi Group/genetics , DNA, Bacterial/isolation & purification , Lyme Disease/drug therapy , Lyme Disease/microbiology , Body Fluids/microbiology , Humans , Polymerase Chain Reaction , Time Factors
4.
Euro Surveill ; 17(2)2012 Jan 12.
Article in English | MEDLINE | ID: mdl-22264863

ABSTRACT

We present four cases of proctitis in HIV-infected men having sex with men (MSM) living in the Czech Republic. The causative agent in all cases was the lymphogranuloma venereum (LGV) biovar of Chlamydia trachomatis. The spread of proctitis caused by C. trachomatis serovars L1­3 among MSM has been observed in several European countries, the United States and Canada since 2003. To our knowledge, no LGV cases in eastern Europe have been published to date.


Subject(s)
Chlamydia trachomatis/isolation & purification , Homosexuality, Male , Lymphogranuloma Venereum/diagnosis , Adult , Anti-Bacterial Agents/therapeutic use , Czech Republic , Doxycycline/therapeutic use , HIV Infections/complications , Humans , Lymphogranuloma Venereum/complications , Lymphogranuloma Venereum/drug therapy , Male , Middle Aged , Proctitis/complications , Proctitis/diagnosis , Proctitis/microbiology , Treatment Outcome
5.
Klin Onkol ; 23(5): 285-92, 2010.
Article in Czech | MEDLINE | ID: mdl-21061678

ABSTRACT

Kaposi's sarcoma was one of the very first diseases which indicated the advent of the AIDS pandemic. Despite the marked fall in its occurrence thanks to the introduction of the cART, Kaposi's sarcoma remains the most frequent tumour in HIV-positive patients and still represents a major diagnostic and therapeutic problem. Particularly in the early stages both the macroscopic and histopathological picture of Kaposi's sarcoma may be very atypical, which can cause diagnostic difficulties right at the time when an early therapy may be most successful. In order to improve both the diagnostics and therapy of Kaposi's sarcoma, close collaboration between physicians taking care of HIV-positive patients--mainly infectologists, dermatologists and pathologists, is necessary.


Subject(s)
HIV Infections/complications , Sarcoma, Kaposi/diagnosis , Adult , Humans , Male , Sarcoma, Kaposi/complications , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/therapy
6.
Folia Microbiol (Praha) ; 54(3): 246-56, 2009.
Article in English | MEDLINE | ID: mdl-19649743

ABSTRACT

Anaplasma phagocytophilum has been first isolated from the blood of two Czech patients simultaneously with a cultivation of Borrelia burgdorferi sensu lato from their erythema migrans lesions. Cultivation of different Borrelia spp. from 12 erythema migrans biopsies, from 2 blood, one liquor and one placenta sample in BSK-H medium was successful. Adapted conventional methods targeting 16S rRNA and OspA genes for real-time polymerase chain reaction (PCR) and partial sequencing of these genes together with microscopical examinations of the blood smears provided a direct detection of the B. afzelii, B. burgdorferi, B. garinii, B. valaisiana and B. bissettii in the skin, B. garinii in the blood, placenta and liquor in 24 (36.3 %) patients, and A. phagocytophilum in 10 (15 %) patients with erythema migrans. Positive indirect IgM immunofluorescence against Anaplasma sp. was obtained in 7 cases, specific IgG antibodies were detected in 12 patients. Three women suffering from erythema migrans in the first trimester had positive PCR for Anaplasma and/or for Borrelia in the blood and two of them, later, in the placenta. Interpretation of laboratory data can bring important contribution to establishing the role of Anaplasma sp. in erythema migrans and forming the principle of precaution with laboratory diagnosis during pregnancy which always should be reflected in the resistance of Anaplasma sp. toward penicillins.


Subject(s)
Anaplasma phagocytophilum/isolation & purification , Borrelia burgdorferi/isolation & purification , Erythema Chronicum Migrans/microbiology , Pregnancy Complications, Infectious/microbiology , Adolescent , Adult , Aged , Anaplasma phagocytophilum/immunology , Antibodies, Bacterial/blood , Antigens, Surface/genetics , Bacterial Outer Membrane Proteins/genetics , Bacterial Vaccines/genetics , Borrelia burgdorferi/genetics , Borrelia burgdorferi/immunology , Diagnosis, Differential , Ehrlichiosis/blood , Ehrlichiosis/diagnosis , Ehrlichiosis/microbiology , Erythema Chronicum Migrans/blood , Erythema Chronicum Migrans/diagnosis , Female , HL-60 Cells , Humans , Lipoproteins/genetics , Lyme Disease/blood , Lyme Disease/diagnosis , Lyme Disease/microbiology , Male , Middle Aged , Placenta/microbiology , Pregnancy , Pregnancy Complications, Infectious/diagnosis
7.
Dermatol Ther ; 21(3): 205-9, 2008.
Article in English | MEDLINE | ID: mdl-18564251

ABSTRACT

Syphilis and lyme borreliosis have similar etiologic, clinical, and epidemiologic characteristics. Both are multisystem infectious disorders spread worldwide. Their clinical course can be divided into three stages and as to spirochetal origin, antibiotic therapy is similar too. Taxonomical relationship of Treponema and Borrelia could explain also congenital manifestations well-known in syphilis, and suggested in borreliosis. Therapy of pregnant women with syphilis and lyme borreliosis should follow the same strategy.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Infectious Disease Transmission, Vertical/prevention & control , Lyme Disease/transmission , Penicillin G/administration & dosage , Pregnancy Complications, Infectious/therapy , Syphilis, Congenital , Syphilis/transmission , Adult , Child, Preschool , Congenital Abnormalities/microbiology , Female , Humans , Infant, Newborn , Lyme Disease/diagnosis , Lyme Disease/drug therapy , Pregnancy , Pregnancy Complications, Infectious/microbiology , Syphilis/diagnosis , Syphilis/drug therapy , Syphilis, Congenital/diagnosis , Syphilis, Congenital/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...